Siyao He

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

Journal: Haematologica

Published: February 24, 2026

The role of KPNA3 in multiple myeloma: implications for targeting nuclear import.

The role of KPNA3 in multiple myeloma: implications for targeting nuclear import.

Journal: Apoptosis : an international journal on programmed cell death

Published: December 04, 2025

Rho-related GTP-binding protein RhoE (RND3) regulates multiple myeloma bone disease.

Rho-related GTP-binding protein RhoE (RND3) regulates multiple myeloma bone disease.

Journal: Cancer cell international

Published: June 30, 2025

Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations.

Beneficial effects of aerobic exercises on multiple myeloma: Mechanisms and clinical observations.

Journal: International journal of cancer

Published: April 04, 2025

LncRNA HCG11 regulates selinexor sensitivity in multiple myeloma.

LncRNA HCG11 regulates selinexor sensitivity in multiple myeloma.

Journal: Biochemical pharmacology

Published: January 18, 2025

The mitochondrial protease ClpP is a promising target for multiple myeloma treatment.

The mitochondrial protease ClpP is a promising target for multiple myeloma treatment.

Journal: Biochemical pharmacology

Published: November 07, 2024

Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib.

Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib.

Journal: Cell death & disease

Published: April 23, 2024

Ferroptosis-related prognostic model of mantle cell lymphoma.

Ferroptosis-related prognostic model of mantle cell lymphoma.

Journal: Open medicine (Warsaw, Poland)

Published: March 05, 2024

Showing 1-8 of 8

Last Updated: 09/26/2026